Bulgarian HealthTech provider Blue Longevity Clinic just raised €2 million to help you live longer

Sofia-based Blue Longevity Clinic, a longevity medicine service provider, has raised €2 million to launch clinics in Greece, Turkey and Bulgaria, supported by proprietary digital technology and advanced diagnostic protocols.

The round was led by Eleven Ventures with participation from Sofia Angels Ventures and several family offices.

“We’re building a new kind of health centre – one that people don’t just visit once a year, but one that becomes part of their lifestyle,” said Ilian Grigorov, Founder and CEO of Blue Longevity. “Longevity is not a single test or therapy – it’s a journey. Our goal is to be the first truly integrated and accessible preventive health platform in the region and one of the global leaders in providing longevity medicine services.”

Founded in 2024 by Ilian Grigorov (City Clinic, Blocks Health), Blagoy Palev (former banker and Co-founder of Blocks Health), and Dr George Vissarakis (former director at Filoktitis Center, Greece), Blue Longevity offers a fully integrated approach to healthy aging, combining in-person functional diagnostics, personalised therapy modules, and a digital app designed to help patients adopt healthy lifestyle choices through microhabit formation.

The vertically integrated model enables high-touch, high-retention care – bridging the current market gap where most longevity clinics are either diagnostic-only or non-personalised.

Inspired by the longevity principles observed in Blue Zones – regions renowned for exceptional human longevity – they offer tailored programnes that address nutrition, physical activity, stress management, and social engagement.

“The transition from reactive sick care to proactive health care is no longer a trend, it’s a global shift,” said Valeri Petrov, Partner at Eleven Ventures. “We’ve been closely tracking this category and believe the SEE region has the potential to become a key hub for medical and longevity tourism. Blue Longevity is one of the first companies locally to combine medical credibility, product depth, and entrepreneurial experience into a scalable model.”

According to the company access to advanced longevity diagnostic tools and treatment protocols has largely remained limited to high-net-worth individuals, often through exclusive, physician-led clinics.

Southeastern Europe has reportedly been slow to adopt such innovations, especially since longevity medicine requires an innovative approach in healthcare delivery that is outside the focus of traditional hospitals. Blue Longevity Clinic aims to democratise longevity medicine to the emerging upper-middle class in the region, which also happens to have one of the largest out-of-pocket health spending ratios in Europe – as per Blue Longevity Clinic.

“Longevity is becoming the new frontier of healthcare – no longer a privilege reserved for eccentric biohackers, reclusive yogis, or billionaires. The science is already advancing at scale, and this will become a trillion-euro industry that helps millions live longer, healthier lives. We believe in BL’s team and their ability to execute on their next healthcare venture, especially given the ripe timing for this mission,” said Milen Ivanov, Managing Partner at Sofia Angels Ventures.

Unlike traditional health providers that focus on diagnosing and treating illness, Blue Longevity is centered on extending healthspan – the number of years one lives in good health.

The clinic’s protocol begins with advanced functional diagnostics that assess key systems such as metabolic health, brain function, gut microbiome, and genetic predispositions. Rather than waiting for disease to manifest, Blue Longevity looks to identify early deviations from optimal function and creates personalised interventions to delay or prevent age-related decline.

Each client receives a physician-led health optimisation plan that can include in-house therapies like Hyperbaric Oxygen Therapy, Cryotherapy, and Red Light Therapy. Through AI-assisted biomarker interpretation and a dynamic longevity report, clients are empowered to continuously improve cardiovascular, metabolic, cognitive, and psychological resilience.

Blue Longevity’s next steps include opening its clinics in Athens, Istanbul and Sofia in September this year. Alongside the physical expansion, the team is investing in further development of its digital app and AI diagnostics engine, aiming to personalise and scale the client experience.

The new capital will be used to fund clinical build-outs, finalise the therapy protocol stack, expand the medical team, and scale the proprietary technology platform.

The post Bulgarian HealthTech provider Blue Longevity Clinic just raised €2 million to help you live longer appeared first on EU-Startups.